Observation of B+ → χc0K+

journal articl

『源氏物語』「須磨」巻における光源氏の描き分け（二） ―賛美表現の使い分けに着目した教材化の試み―

departmental bulletin pape

Chip Formation Behaviour in Ultra-Precision Cutting of Electroless Nickel Plated mold Substrates

journal articl

マルチメディア コンテンツ ト MPEG-7 : メタジョウホウ ニヨリ カンリサレタ マルチメディア コンテンツ ト ソノ アプリケーション/ナラ センタン カガク ギジュツ ダイガクイン ダイガク デンシ トショカンガク コウザ

video/mp4講演日: 平成20年10月30日講演場所: 附属図書館マルチメディア提示室1講演者所属: リコーソフトウェア株式会社主席プロジェクトマネージャ講演者所属: リコーソフトウェア株式会社上席ソリューションスペシャリストvide

Supplementary Figures 1 - 15 from Nonequivalent Gene Expression and Copy Number Alterations in High-Grade Serous Ovarian Cancers with <i>BRCA1</i> and <i>BRCA2</i> Mutations

PDF file - 1609K</p

Supplementary Table 16 from Nonequivalent Gene Expression and Copy Number Alterations in High-Grade Serous Ovarian Cancers with <i>BRCA1</i> and <i>BRCA2</i> Mutations

PDF file - 28K</p

Supplementary Table 17 from Nonequivalent Gene Expression and Copy Number Alterations in High-Grade Serous Ovarian Cancers with <i>BRCA1</i> and <i>BRCA2</i> Mutations

PDF file - 22K</p

Supplementary Methods and Tables 1 - 15, 19 from Nonequivalent Gene Expression and Copy Number Alterations in High-Grade Serous Ovarian Cancers with <i>BRCA1</i> and <i>BRCA2</i> Mutations

PDF file - 338K</p

Supplementary Table 18 from Nonequivalent Gene Expression and Copy Number Alterations in High-Grade Serous Ovarian Cancers with <i>BRCA1</i> and <i>BRCA2</i> Mutations

PDF file - 24K</p

Supplementary Figures S1 - S6 from Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition

Supplementary Figure S1 - Validation of CCNE1 and CDK2 siRNA-mediated knockdown Supplementary Figure S2 - Validation of CDK2 knockdown mediated by shRNA in vitro and in vivo Supplementary Figure S3 - FACS plots validating incorporation and induction of shRNA into OVCAR3 and CAOV3 cells Supplementary Figure S4 - Characterisation of CDK resistant lines and supplementary data supporting drug treatment Supplementary Figure S5 - Extended Oncoprint figure from TCGA Supplementary Figure S6 - Validation of FT282 over-expression constructs</p